NCT06805812 2025-02-03PALMARES-2Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoRecruiting3,500 enrolled
NCT06075758 2025-01-14A Study of Ribociclib in Combination With Hormonal Therapy in HR+/HER2- Advanced or Metastatic Breast CancerNovartisRecruiting550 enrolled
NCT06587789 2024-11-21Ribociclib in Combination With Adjuvant Endocrine Therapy for Patients With Early High-risk HR+HER2- Breast CancerSecond Affiliated Hospital, School of Medicine, Zhejiang UniversityRecruiting286 enrolled